Skip to content
Clinical Trials – home
NorwayBack to Norway

Clinical trials in Skedsmokorset – page 39

607 clinical trials in Skedsmokorset, Norway. Every trial is listed in the EU Clinical Trials Register and updated daily.

NorwayOur site in NorwayKliniske-Studier.no(opens in a new tab)
Skedsmokorset at a glance
607
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

607 trials in Skedsmokorset

Open in trial search

Study on the Safety and Pharmacokinetics of Risdiplam in Infants with Spinal Muscular Atrophy

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years
  • Substances:Risdiplam
  • Sponsor:F. Hoffmann-La Roche AG

Study of Nivolumab and Relatlimab for Patients with Stage III-IV Melanoma After Surgery

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Bristol Myers Squibb International Corporation

Osteoarthritis

Not recruiting

Study of methotrexate compared to placebo for treating pain in patients with erosive hand osteoarthritis

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Methotrexate
  • Sponsor:Diakonhjemmet Sykehus AS

Study of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Glaxosmithkline Research & Development Limited

Plasma cell myeloma

Not recruiting

Study of Elranatamab, Dexamethasone, and Diphenhydramine Hydrochloride for Patients with High-Risk Smoldering Multiple Myeloma

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Emn Trial Office S.r.l. Impresa Sociale

Study on Alectinib and Durvalumab for Patients with Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Alectinib
  • Sponsor:F. Hoffmann-La Roche AG

Plasma cell myeloma

Not recruiting

Study of Isatuximab, Lenalidomide, and Dexamethasone for Patients with High-Risk Smoldering Multiple Myeloma

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Codeine Phosphate
  • Sponsor:Sanofi-Aventis Recherche & Developpement

K-ras gene mutation+2

Not recruiting

Study on Sotorasib for Patients with Advanced KRAS G12C-Mutated Non-Small Cell Lung Cancer and Comorbidities

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Sotorasib
  • Sponsor:Vestre Viken HF

Colorectal cancer+6

Not recruiting

Study of INCB099280 and Ipilimumab for Patients with Advanced Solid Tumors

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:INCB099280
  • Sponsor:Incyte Corp.

Glioblastoma

Not recruiting

Study on Lomustine with or without Additional Brain Radiation for Patients with Recurrent Glioblastoma

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Lomustine
  • Sponsor:European Organisation For Research And Treatment Of Cancer

Gastric cancer

Not recruiting

Study of Bemarituzumab and Chemotherapy for Patients with Advanced Stomach or Gastroesophageal Cancer with FGFR2b Overexpression

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Bemarituzumab
  • Sponsor:Amgen Inc.

Gastric cancer+7

Not recruiting

Study on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Bristol Myers Squibb International Corporation

Other cities in Norway

The busiest research cities in the country

All 53 cities in Norway

Clinical research in Skedsmokorset

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials focusing on lipoprotein management and prevention of major cardiovascular events in patients with established cardiovascular disease.

  • Cardiovascular Disease Prevention
  • Lipid Management
  • Cardiovascular Event Reduction

Studies evaluating novel therapeutic approaches for reducing cardiovascular mortality and improving patient outcomes.

02 Stroke Prevention

Research examining new treatments for preventing stroke and systemic embolism in patients with atrial fibrillation, comparing innovative therapies with established medications.

  • Atrial Fibrillation Management
  • Anticoagulation Therapy
  • Stroke Risk Reduction

Trials focused on developing safer and more effective treatments for stroke prevention.

03 Vascular Disease Research

Studies investigating treatments for atherosclerotic cardiovascular disease, with emphasis on preventing major adverse cardiovascular events.

  • ASCVD Management
  • Cardiovascular Risk Reduction
  • LDL cholesterol Control

Evaluation of novel therapies targeting established vascular disease and its complications.

04 Pulmonary Medicine

Clinical research examining the effectiveness of combination therapies for Chronic Obstructive Pulmonary Disease, focusing on cardiopulmonary outcomes.

  • COPD Treatment
  • Respiratory Medicine
  • Bronchodilator Therapy

Investigation of advanced treatment options for improving respiratory function and quality of life.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.